FDA Drugs (New Approvals & NDA)Original article
Unique Pharmaceutical Laboratories (A Div. of J. B. Chemicals & Pharmaceuticals Ltd.) Issues Voluntary Nationwide Recall of Cetirizine Hydrochloride Tablets USP 5 mg Due to Potential Cross Contamination with Ranitidine
RegulatoryCetirizine Hydrochloride Tablets USP 5 mgRanitidineNegative
AI Analysis
Summary
Unique Pharmaceutical Laboratories voluntarily recalled four lots of Cetirizine Hydrochloride Tablets USP 5 mg due to potential cross contamination with Ranitidine. The recall was issued to the consumer level on July 18, 2026.
Outcome Details
Voluntary nationwide recall due to potential cross contamination with Ranitidine
Importance:4/10
Sentiment:
-0.80
recallsafetycross contaminationquality control
Related Companies
Read the original article
Published by FDA Drugs (New Approvals & NDA) on July 20, 2026 10:00 PM